Begni, V.; Sanson, A.; Luoni, A.; Sensini, F.; Grayson, B.; Munni, S.; Neill, J.C.; Riva, M.A.
Towards Novel Treatments for Schizophrenia: Molecular and Behavioural Signatures of the Psychotropic Agent SEP-363856. Int. J. Mol. Sci. 2021, 22, 4119.
https://doi.org/10.3390/ijms22084119
AMA Style
Begni V, Sanson A, Luoni A, Sensini F, Grayson B, Munni S, Neill JC, Riva MA.
Towards Novel Treatments for Schizophrenia: Molecular and Behavioural Signatures of the Psychotropic Agent SEP-363856. International Journal of Molecular Sciences. 2021; 22(8):4119.
https://doi.org/10.3390/ijms22084119
Chicago/Turabian Style
Begni, Veronica, Alice Sanson, Alessia Luoni, Federica Sensini, Ben Grayson, Syeda Munni, Joanna C. Neill, and Marco A. Riva.
2021. "Towards Novel Treatments for Schizophrenia: Molecular and Behavioural Signatures of the Psychotropic Agent SEP-363856" International Journal of Molecular Sciences 22, no. 8: 4119.
https://doi.org/10.3390/ijms22084119
APA Style
Begni, V., Sanson, A., Luoni, A., Sensini, F., Grayson, B., Munni, S., Neill, J. C., & Riva, M. A.
(2021). Towards Novel Treatments for Schizophrenia: Molecular and Behavioural Signatures of the Psychotropic Agent SEP-363856. International Journal of Molecular Sciences, 22(8), 4119.
https://doi.org/10.3390/ijms22084119
